ALPS Advisors’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-46,222
| Closed | -$1.83M | – | 1014 |
|
|
2024
Q1 | $1.83M | Buy |
46,222
+6,631
| +17% | +$263K | 0.01% | 369 |
|
|
2023
Q4 | $755K | Buy |
+39,591
| New | +$755K | 0.01% | 544 |
|
|
2022
Q2 | – | Sell |
-30,030
| Closed | -$269K | – | 1098 |
|
|
2022
Q1 | $269K | Sell |
30,030
-3,785
| -11% | -$33.9K | ﹤0.01% | 779 |
|
|
2021
Q4 | $468K | Buy |
33,815
+4,511
| +15% | +$62.4K | 0.01% | 528 |
|
|
2021
Q3 | $313K | Sell |
29,304
-2,194
| -7% | -$23.4K | ﹤0.01% | 854 |
|
|
2021
Q2 | $283K | Buy |
+31,498
| New | +$283K | ﹤0.01% | 865 |
|